Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Sanofi will build an “end-to-end” influenza vaccine manufacturing facility in Toronto following an announcement Wednesday that the global pharmaceutical giant, the federal government and the province of Ontario will invest close to a billion dollars in the project.

The nearly 50-50 split of public and private investment will ensure that Canada has an operational domestic vaccine manufacturing plant by 2026 that can make enough vaccine for the entire population within about six months of the World Health Organization identifying a pandemic flu strain, the federal government said Wednesday.

“When it comes to the next pandemic flu, we should be self-sufficient,” Industry Minister François-Philippe Champagne said.

Story continues below advertisement

Sanofi will spend $455-million on the facility, while the federal government is pledging $415-million and Ontario will kick in $55-million. The facility will be used to make Sanofi’s Fluzone vaccine, a high-dose quadrivalent influenza shot, which is supplied to Canada, the United States and Europe.

Mr. Champagne said negotiations with Sanofi are continuing over a contract to supply the federal government with vaccines during a future pandemic. The federal government did not provide more detail on those talks, but Mr. Champagne told CBC’s Power and Politics that the deal would give Canada priority access in any future pandemic to vaccines developed at the site .

“That’s the basis of the investment that we’ve been making, obviously, is the fact that they can serve first the domestic market,” Mr. Champagne said. He also said the company would be able to make 76 million shots for Canada within six months.

While the facility is being made with a focus on influenza pandemics, Vincent Hignot, a senior vice-president at Sanofi, said the new site will be able to complete critical manufacturing stages for other types of vaccines that target other diseases.

“The formulation, filling, inspection and packaging capacity are also very important and these steps are common for all vaccines. If you are talking about mRNA or whatever vaccines, it will be suitable as well,” Mr. Hignot said. Those are important parts of the manufacturing process that were lacking in Canada and worldwide during the COVID-19 pandemic, he said.

“With this project, Canada will have such capacities in the future,” Mr. Hignot said.

Sanofi’s Toronto manufacturing site already makes vaccines for diseases such as polio and tetanus. The company is also developing a COVID-19 vaccine, but poor results in their first Phase 1/2 clinical trial prompted them to launch a new trial.

Story continues below advertisement

Sanofi will also invest $79-million annually for eight years in research and development work in Canada, Mr. Champagne said. The company did not provide more details on that part of the announcement.

At a news conference in Toronto, several company and government representatives highlighted the need for Canada to be better prepared for any future pandemic as the country grapples with a third wave of the COVID-19 pandemic.

In Ontario, hospitals reported the highest number of COVID-19 patients in critical care since the start of the pandemic. Despite that, the province had still planned to loosen restrictions, but Premier Doug Ford said an announcement from his government was expected on Thursday.

The federal and provincial government have frequently been at loggerheads in the past few months, with Mr. Ford criticizing the federal government for a sluggish start to the vaccine rollout. On Tuesday, he said the province still didn’t have predictability in supplies or deliveries, which he argued was further challenging Ontario’s vaccination campaign.

Mr. Ford and federal ministers struck a friendly tone at the joint news conference, with the Premier saying he’s not “taking the bait” on a question about his government’s frustrations over federal vaccine procurement and critiques from federal Liberal MPs about the amount of doses the province has held back in storage for future vaccination appointments.

“Sure, we’ll have bumps in the road,” Mr. Ford said. “We’ll have a few differences – but what family doesn’t?”

Story continues below advertisement

Editor’s note: An earlier version incorrectly said Ontario was contributing $50-million to the project.

Know what is happening in the halls of power with the day’s top political headlines and commentary as selected by Globe editors (subscribers only). Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies